SCHEMBL3932964

SCHEMBL3932964

O=C(Nc1ccc(Cl)c(C(=O)Nc2ccc(Br)nc2)c1)c1cccc(C(F)(F)F)c1

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CSF1R P07333 10/20 0.74
BRAF P15056 3/20 0.74
MAPK14 Q16539 3/20 0.74
CYP2C9 P11712 2/20 0.74
JAK2 O60674 1/20 0.74
PDGFRB P09619 1/20 0.74
FGFR1 P11362 1/20 0.74
EPHB4 P54760 1/20 0.74
PTK2 Q05397 1/20 0.74
BTK Q06187 5/20 0.67
KCNQ3 O43525 2/20 0.66
KCNQ2 O43526 2/20 0.66
KCNE1 P15382 2/20 0.66
KCNQ1 P51787 2/20 0.66
KCNQ5 Q9NR82 1/20 0.62
LCK P06239 5/20 0.59
KDR P35968 1/20 0.59
ABL1 P00519 1/20 0.56
KIT P10721 1/20 0.56
SRC P12931 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27720386 0.88 CSF1R (0.74) CSF1RBRAFMAPK14CYP2C9JAK2
SCHEMBL3933086 0.88 CSF1R (0.80) CSF1RBRAFMAPK14CYP2C9JAK2
SCHEMBL14286496 0.87 CSF1R (0.75) CSF1RBRAFMAPK14CYP2C9JAK2
SCHEMBL2494570 0.87 CSF1R (0.81) CSF1RBRAFMAPK14CYP2C9JAK2
SCHEMBL3933304 0.86 MAPK14 (0.72) CSF1RBRAFMAPK14CYP2C9JAK2
SCHEMBL3936664 0.85 CSF1R (1.00) CSF1RBRAFMAPK14CYP2C9JAK2
SCHEMBL1276893 0.84 CSF1R (1.00) CSF1RBRAFMAPK14CYP2C9JAK2
SCHEMBL2950273 0.84 CSF1R (0.81) CSF1RBRAFMAPK14CYP2C9JAK2
SCHEMBL27720384 0.84 CSF1R (0.68) CSF1RBRAFMAPK14CYP2C9JAK2
SCHEMBL2497726 0.83 BTK (0.83) CSF1RBRAFMAPK14CYP2C9JAK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1831198-B1 PYRIDINE CARBOXAMIDE DERIVATIVES FOR USE AS ANTICANCER AGENTS ASTRAZENECA AB (SE) 2009-04-08 EP disclosed
CN-101128454-A Pyridine carboxamide derivatives for use as anticancer agents ASTRAZENECA AB (SE) 2008-02-20 CN disclosed
WO-2006067445-A2 CSF-1R KINASE INHIBITORS ASTRAZENECA AB (SE) 2006-06-29 WO disclosed